Skip to main content

Court of Appeals Reinstates Birmingham Hip Implant Lawsuit

Court of Appeals Reinstates Birmingham Hip Implant Lawsuit

Court of Appeals Reinstates Birmingham Hip Implant Lawsuit

Introduction

The 9th Circuit U.S. Court of Appeals confirmed on restoring a Birmingham Hip Resurfacing lawsuit filed by a plaintiff against Smith & Nephew alleging the manufacturer of failing to warn about the system's health risk.

The lawsuit, filed by the plaintiff in April 2016, indicates the hip implants were defective and not compliant to the federal Food, Drug and Cosmetics Act and its regulations. The case was dismissed by the district court which was reinstated by a common three-judge appeals court panel. The Court of Appeals states that the plaintiff’s proposed amended complaint sufficiently alleges a failure-to-warn claim under Arizona law.

Several Birmingham Hip Replacement lawsuits are federally-filed against Smith & Nephew, 140 of which have been combined into a major federal litigation. Hip replacement lawsuits continue to be filed under a related hip litigation involving Stryker Hip Replacement lawsuits, centralized before U.S. District Judge Indira Talwani under MDL No. 2768 – in Re: Stryker LFIT V40 Femoral Head Products Liability Litigation.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!